Join FDA Generic Drugs Program Staff at the upcoming FDA/DIA Complex Generic Drug-Device Combination Products Conference

You’re invited to attend an upcoming conference on complex generic drug-device combination products!

Join scientists and policy experts from the FDA, and other leaders in the field, as we discuss current scientific and regulatory perspectives at the FDA and DIA co-sponsored Complex Generic Drug-Device Combination Products Conference. This virtual conference will be held October 19-20, 2020. AGENDA · SPEAKER LIST · REGISTRATION Why Attend? Get the latest updates on innovative scientific methods and ongoing research efforts to address the challenges associated with the development of generic drug-device combination products. Bring your questions and have them answered by leaders in industry, academia, and FDA. Learn about the scientific considerations and associated challenges in demonstrating pharmaceutical equivalence for generic drug-device combination products. Join in scientific discussion on quality and manufacturing issues related to generic drug-device combination products. Hot Topics Complex generic drug-device combination product regulation Product development, quality considerations, and demonstrating bioequivalence for generic complex products, such as inhalation and nasal products, injection devices, intravaginal rings and intrauterine systems, and topical and transdermal drug-device combination products Post-marketing pharmacovigilance and lifecycle management challenges